Nothing Special   »   [go: up one dir, main page]

PT2130044T - Método para a identificação de risco de distúrbio da tiróide - Google Patents

Método para a identificação de risco de distúrbio da tiróide

Info

Publication number
PT2130044T
PT2130044T PT87256574T PT08725657T PT2130044T PT 2130044 T PT2130044 T PT 2130044T PT 87256574 T PT87256574 T PT 87256574T PT 08725657 T PT08725657 T PT 08725657T PT 2130044 T PT2130044 T PT 2130044T
Authority
PT
Portugal
Prior art keywords
thyroid disorder
identifying risk
identifying
risk
thyroid
Prior art date
Application number
PT87256574T
Other languages
English (en)
Inventor
Harris Margolin David
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of PT2130044T publication Critical patent/PT2130044T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/635Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70592CD52
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/046Thyroid disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PT87256574T 2007-02-16 2008-02-15 Método para a identificação de risco de distúrbio da tiróide PT2130044T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90173207P 2007-02-16 2007-02-16

Publications (1)

Publication Number Publication Date
PT2130044T true PT2130044T (pt) 2017-02-03

Family

ID=39434244

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87256574T PT2130044T (pt) 2007-02-16 2008-02-15 Método para a identificação de risco de distúrbio da tiróide

Country Status (22)

Country Link
US (3) US20100136587A1 (pt)
EP (2) EP2130044B1 (pt)
JP (2) JP5662684B2 (pt)
CN (2) CN101657721B (pt)
AU (1) AU2008219097B2 (pt)
BR (1) BRPI0807601B8 (pt)
CA (1) CA2678199A1 (pt)
CY (1) CY1118663T1 (pt)
DK (1) DK2130044T3 (pt)
ES (1) ES2612558T3 (pt)
HK (1) HK1257419A1 (pt)
HR (1) HRP20170121T1 (pt)
HU (1) HUE031421T2 (pt)
IL (2) IL200314A (pt)
LT (1) LT2130044T (pt)
MX (1) MX2009008642A (pt)
PL (1) PL2130044T3 (pt)
PT (1) PT2130044T (pt)
RS (1) RS55636B1 (pt)
RU (1) RU2013120485A (pt)
SI (1) SI2130044T1 (pt)
WO (1) WO2008103292A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498528B2 (en) 2006-09-13 2016-11-22 Genzyme Corporation Treatment of multiple sclerosis (MS)
FR2934129B1 (fr) * 2008-07-24 2014-05-02 Oreal Procede de traitement cosmetique.
US20100167421A1 (en) * 2008-09-19 2010-07-01 University Of Utah Research Foundation Methods for identification and prediction of multiple sclerosis disease and therapy response
CN106257288A (zh) * 2016-08-15 2016-12-28 余洋 一种血清TPOAb IgG4水平检测方法
EP3817761A4 (en) 2018-07-02 2021-09-08 Siemens Healthcare Diagnostics Inc. NEW IMMUNOLOGICAL DOSAGE OF THYROID PEROXIDASE AUTO-ANTIBODIES
KR102469743B1 (ko) * 2020-06-10 2022-11-22 주식회사 타이로스코프 약물 복용에 따른 갑상선 기능 모니터링 방법, 이를 수행하는 모니터링 서버 및 사용자 단말
EP4001919A1 (en) * 2020-11-13 2022-05-25 Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal Predictive biomarkers of autoimmunity in patients treated with alemtuzumab
WO2024158259A1 (ko) * 2023-01-27 2024-08-02 주식회사 타이로스코프 대상에 대한 갑상선기능이상증의 예측방법 및 시스템

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5846534A (en) 1988-02-12 1998-12-08 British Technology Group Limited Antibodies to the antigen campath-1
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
GB9125768D0 (en) 1991-12-04 1992-02-05 Hale Geoffrey Therapeutic method
GB2265713A (en) * 1992-05-16 1993-10-06 R S R Limited Assay for autoantibodies against thyroglobulin or thyroid peroxidase
DE19710211C2 (de) * 1997-03-12 1999-12-16 Brahms Diagnostica Gmbh Verfahren zur Bestimmung von Schilddrüsen-Autoantikörpern
GB9823397D0 (en) * 1998-10-27 1998-12-23 Rsr Ltd Assays for thyroid autoantibodies
US20060130161A1 (en) * 2004-10-12 2006-06-15 Carantech, Inc. Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes
US9498528B2 (en) * 2006-09-13 2016-11-22 Genzyme Corporation Treatment of multiple sclerosis (MS)

Also Published As

Publication number Publication date
MX2009008642A (es) 2009-10-20
BRPI0807601B8 (pt) 2021-07-27
JP6058585B2 (ja) 2017-01-11
US10648986B2 (en) 2020-05-12
US9664688B2 (en) 2017-05-30
US20170307629A1 (en) 2017-10-26
PL2130044T3 (pl) 2017-04-28
EP2538217A1 (en) 2012-12-26
HRP20170121T1 (hr) 2017-03-24
IL200314A (en) 2015-11-30
EP2130044A1 (en) 2009-12-09
BRPI0807601A2 (pt) 2014-05-06
CN108303546A (zh) 2018-07-20
IL200314A0 (en) 2010-04-29
JP2010519512A (ja) 2010-06-03
WO2008103292A1 (en) 2008-08-28
ES2612558T3 (es) 2017-05-17
AU2008219097A1 (en) 2008-08-28
CA2678199A1 (en) 2008-08-28
IL242391A (en) 2017-09-28
CN108303546B (zh) 2023-01-03
DK2130044T3 (en) 2017-02-06
HUE031421T2 (hu) 2017-07-28
CN101657721A (zh) 2010-02-24
SI2130044T1 (sl) 2017-03-31
BRPI0807601B1 (pt) 2021-02-23
EP2130044B1 (en) 2016-10-26
JP2014149313A (ja) 2014-08-21
RU2013120485A (ru) 2014-11-20
HK1257419A1 (zh) 2019-10-18
CN101657721B (zh) 2018-02-23
AU2008219097B2 (en) 2011-06-23
US20130095507A1 (en) 2013-04-18
RS55636B1 (sr) 2017-06-30
RU2009134313A (ru) 2011-03-27
LT2130044T (lt) 2017-02-10
US20100136587A1 (en) 2010-06-03
CY1118663T1 (el) 2017-07-12
JP5662684B2 (ja) 2015-02-04

Similar Documents

Publication Publication Date Title
HK1257419A1 (zh) 鑒定甲狀腺疾病風險的方法
IL239277A0 (en) A method for identifying risk factors for diseases
GB201111162D0 (en) A riser and a method for identifying a riser
PL2325648T3 (pl) Sposób wykrywania nowotworów
IL210660A0 (en) Method and system for filming
GB0813278D0 (en) Method for inhibiting corrosion
EP2373558A4 (en) METHOD AND SYSTEM FOR PROVIDING DOCK ASSISTANCE
EP2330426A4 (en) AUTOMATIC ANALYSIS SYSTEM
PT2096102E (pt) Processo para a produção de metileno-difenil-diisocianatos
GB0713396D0 (en) Inspection method
GB2465502B (en) Method for identifying and selecting cardiomyocytes
HK1161543A1 (zh) 促進紅細胞生成的化合物和方法
HK1162722A1 (en) Optical reading method
EG26381A (en) Method for the identification of oxidizing bacteria for propane
ZA200803212B (en) Method for determining preeclampsia risk
EP2180643A4 (en) INVESTIGATIONS
EP2541253A4 (en) METHOD FOR EXAMINING ACUTE RENAL DISORDER
GB2457927B (en) Method and system for resolving deadlocks
EP2438194A4 (en) METHODS OF SCREENING AND IDENTIFYING COMPOUNDS
EP2274534A4 (en) METHOD FOR IDENTIFYING POSITIONS OF BRAKE MONITORING DEVICES
EP2325161A4 (en) METHOD FOR PRODUCING A HYDROXYESTER COMPOUND
EP2229580A4 (en) METHOD FOR APPLICATION OF SAMPLES
TWI365995B (en) Method for tetsing sata interface
ZA201101179B (en) Method and system for filming
ZA201005707B (en) Method for mining